Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease
about
Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approachThe regulation of inflammation by interferons and their STATsGenome-wide diet-gene interaction analyses for risk of colorectal cancer.Systematically Prioritizing Functional Differentially Methylated Regions (fDMRs) by Integrating Multi-omics Data in Colorectal CancerTranscriptional and Molecular Pathways Activated in Mesenteric Adipose Tissue and Intestinal Mucosa of Crohn's Disease Patients.Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis.Growth Hormone Resistance-Special Focus on Inflammatory Bowel Disease.S1pping fire: Sphingosine-1-phosphate signaling as an emerging target in inflammatory bowel disease and colitis-associated cancerCXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.Effects of baicalin in CD4 + CD29 + T cell subsets of ulcerative colitis patients.Immunohistochemical analysis of retinoblastoma and β-catenin as an assistant tool in the differential diagnosis between Crohn's disease and ulcerative colitis.Engagement of two distinct binding domains on CCL17 is required for signaling through CCR4 and establishment of localized inflammatory conditions in the lung.High-throughput multi-analyte Luminex profiling implicates eotaxin-1 in ulcerative colitis.Isolation and optimization for affinity and biophysical characteristics of anti-CCL17 antibodies from the VH1-69 germline gene.Effect of Infliximab in oxidised serum albumin levels during experimental colitis.Reduced incidence of Crohn's disease in systemic sclerosis: a nationwide population study.Computational Prediction and Validation of BAHD1 as a Novel Molecule for Ulcerative Colitis.Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat's in the fireEmerging neuropeptide targets in inflammation: NPY and VIPExpression Profile of p53 and p21 in Large Bowel Mucosa as Biomarkers of Inflammatory-Related Carcinogenesis in Ulcerative ColitisCD14+CD33+ myeloid cell-CCL11-eosinophil signature in ulcerative colitis.Gene and Network Analysis of Common Variants Reveals Novel Associations in Multiple Complex Diseases.NADPH oxidase in brain injury and neurodegenerative disordersIdentification of Candidate Genes Related to Inflammatory Bowel Disease Using Minimum Redundancy Maximum Relevance, Incremental Feature Selection, and the Shortest-Path Approach.Investigational cytokine-targeted therapies for ulcerative colitis.Therapy with stem cells in inflammatory bowel diseaseExperimental appendicitis and appendectomy modulate the CCL20-CCR6 axis to limit inflammatory colitis pathology.Down the line from genome-wide association studies in inflammatory bowel disease: the resulting clinical benefits and the outlook for the future.Anti-inflammatory Effects of Fungal Metabolites in Mouse Intestine as Revealed by In vitro Models.Indigo Naturalis Ameliorates Oxazolone-Induced Dermatitis but Aggravates Colitis by Changing the Composition of Gut Microflora.Epithelial-specific ETS-1 (ESE1/ELF3) regulates apoptosis of intestinal epithelial cells in ulcerative colitis via accelerating NF-κB activation.Immunological profiling of patients with ulcerative colitis leads to identification of two inflammatory conditions and CD1a as a disease markerHigh-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis.Increased IL-17A/IL-17F expression ratio represents the key mucosal T helper/regulatory cell-related gene signature paralleling disease activity in ulcerative colitis.Assessment of the validity of a multigene analysis in the diagnostics of inflammatory bowel disease.Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study.Regulation and Sensing of Inflammasomes and Their Impact on Intestinal Health.Anti-inflammatory effects and mechanisms of vagal nerve stimulation combined with electroacupuncture in a rodent model of TNBS-induced colitis.Integrated strategy of differentially expressed genes associated with ulcerative colitis.Monoglyceride lipase gene knockout in mice leads to increased incidence of lung adenocarcinoma.
P2860
Q26747744-4406A482-29BC-42FB-ABB1-213EE87A79BFQ26829387-2688A38D-E4E5-468C-9986-1E6E47D76180Q29417001-7C58435B-05EE-4AFA-9BE0-9AEAC6CE7BE3Q30659867-FBC8E7D3-E73C-488B-BE7B-579A8FA7456EQ33592962-F80D7591-B630-4276-9687-03300B4687CDQ33723775-1D45E80A-6C57-45F1-903B-16873B3036F7Q33755171-0A1CE1B9-1A78-4624-981F-492BD8C1A05DQ33857794-E59A6683-6A45-45B5-BEAA-4DB6A78D8853Q33864128-EF1D96C8-57FD-4021-B249-FD31EC088A37Q34467240-614C945A-0397-45B2-9CF5-1B5E4A159096Q34962856-096C991D-8C75-4C6F-B15C-790810E65941Q35067528-47C4D52F-E944-4AAB-8030-E810A4F44815Q35075300-F0AE8EB3-0E80-4CE2-AE08-33F3075FE557Q35151385-093CD053-9E4A-43E9-84FA-4D881CD6C4F4Q35405853-B0ACEA46-B93F-4A93-9DA2-638E84B52532Q35775371-7FCBAE81-B99A-4AF8-A197-BFA40068BA1AQ35860292-0228F800-B98D-4FBF-A369-674A9800E6E7Q36708344-319EC743-0E46-4A68-9471-84337082DE0EQ36923640-6C02AC86-4363-4E36-839D-186BD42F0293Q37192429-7CCA35F6-4684-42A0-BD32-A560E6AD76F9Q37238312-EA9F7086-52E9-47DF-986D-1C2927FA24EDQ37347795-5CE6F43E-E581-4FC7-964C-BEE47AC377AAQ37589114-82DB0ED9-436E-4E35-A59C-4BFCFC717B6DQ37672624-D9E8AD2B-5A18-4FC6-ADD0-800FB55B54A1Q38117175-9633CD22-9180-477A-A976-E7A63EE6F1C2Q38191582-59CB4B06-C4EE-4FF3-ABEE-44DD0D634524Q38224879-10DC6A0C-550F-4A8F-BF0B-4AC2CCF8610EQ38286034-4C157BB6-67EF-40C0-B63A-E5BF088669C1Q38694522-C81732A4-2E99-4BAB-B657-A843E6534F4CQ38797790-77E7A648-538B-4E93-8041-EB7D10EE3819Q38880724-D16A2EBF-9E85-44B9-B737-F4ECB310D660Q39220077-62E724D8-673D-49E5-A77D-5496AC23333AQ41185159-386FD468-D7C3-449A-B085-262F1B89E675Q43700132-261C3FF0-F5CD-4F2E-BC0A-30AE4ED945C7Q44091952-962DC6B4-F392-4F92-8F95-EB2A604688DEQ44696806-13409DD9-6561-46B6-9B92-8F1BD77CD3B3Q47146914-BDF0651E-4EAA-43E9-8B67-07A612C6F710Q47292177-5BFFBE2C-BA07-4AC6-8E93-BC5C92A2087BQ47749878-BCB809C9-4784-4E8C-9BFB-A06864C9E54FQ49952999-16EADA71-92FA-4F1F-9275-28BC9072066A
P2860
Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Immune markers and differentia ...... ve colitis and Crohn's disease
@ast
Immune markers and differentia ...... ve colitis and Crohn's disease
@en
type
label
Immune markers and differentia ...... ve colitis and Crohn's disease
@ast
Immune markers and differentia ...... ve colitis and Crohn's disease
@en
prefLabel
Immune markers and differentia ...... ve colitis and Crohn's disease
@ast
Immune markers and differentia ...... ve colitis and Crohn's disease
@en
P2093
P2860
P356
P1476
Immune markers and differentia ...... ve colitis and Crohn's disease
@en
P2093
George P Christophi
Paul T Massa
Philip G Holtzapple
Steve K Landas
P2860
P304
P356
10.1002/IBD.22957
P577
2012-03-29T00:00:00Z